SALTERS MEDICAL PRACTICE — All Prescriptions & Medications — Page 3
Practice Code: M81034 | DROITWICH, WR9 8RD
Showing results 101-150 of 588
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Sitagliptin | 365 | 14.7K | £1.1K | -6.4% ▼ |
| Mirabegron | 352 | 16.4K | £15.1K | -12.4% ▼ |
| Progesterone | 349 | 30.1K | £6.6K | -16.6% ▼ |
| Trimethoprim | 343 | 14.1K | £857 | +67.9% ▲ |
| Atenolol | 335 | 21.2K | £456 | -44.4% ▼ |
| Insulin aspart | 325 | 2,484 | £18.2K | -14.6% ▼ |
| Warfarin sodium | 322 | 23.2K | £1.7K | -31.7% ▼ |
| Pravastatin sodium | 322 | 15.3K | £679 | -0.8% vs avg |
| Lamotrigine | 320 | 36.5K | £10.7K | -45.8% ▼ |
| Solifenacin | 318 | 14.9K | £688 | -33.4% ▼ |
| 318 | 365 | £1.9K | +34.6% ▲ | |
| Sildenafil (Erectile Dysfunction) | 316 | 3,224 | £622 | -37.3% ▼ |
| Estradiol with progestogen | 313 | 12.4K | £10.4K | -8.2% ▼ |
| Esomeprazole | 303 | 20.4K | £1.6K | -25.1% ▼ |
| Rivaroxaban | 303 | 11.7K | £8.3K | -50.5% ▼ |
| Estriol | 291 | 4,783 | £4.8K | +36.8% ▲ |
| Irbesartan | 283 | 16.5K | £671 | +16.1% ▲ |
| Oxycodone hydrochloride | 282 | 25.5K | £2.1K | +10.2% ▲ |
| Budesonide | 280 | 431 | £10.7K | -48.3% ▼ |
| Mebeverine hydrochloride | 279 | 23.7K | £1.4K | -10.1% ▼ |
| 278 | 4,359 | £2.8K | +172.1% ▲ | |
| Clarithromycin | 276 | 5,796 | £1.3K | +12.5% ▲ |
| Ketoprofen | 272 | 40.8K | £1.8K | +658.1% ▲ |
| Co-amoxiclav (Amoxicillin/clavulanic acid) | 270 | 7,473 | £873 | +76.8% ▲ |
| Carbamazepine | 269 | 29.5K | £1.6K | -9.4% ▼ |
| Diclofenac diethyl | 267 | 41.7K | £2.7K | -24.8% ▼ |
| Lactulose | 266 | 150.5K | £1.4K | -19.2% ▼ |
| Phenoxymethylpenicillin (Penicillin V) | 264 | 26.3K | £1.1K | -13.9% ▼ |
| Beclometasone dipropionate | 261 | 290 | £911 | +21.4% ▲ |
| 257 | 33.8K | £1.4K | +96.2% ▲ | |
| Promethazine hydrochloride | 246 | 24.5K | £2.0K | -31.2% ▼ |
| Fluticasone furoate | 246 | 321 | £2.3K | +27.0% ▲ |
| Indapamide | 245 | 12.4K | £525 | -71.6% ▼ |
| 239 | 119.7K | £1.5K | -9.4% ▼ | |
| Cyclizine hydrochloride | 238 | 11.1K | £389 | +47.5% ▲ |
| Fluticasone/umeclidinium/vilanterol | 236 | 303 | £12.8K | +0.7% vs avg |
| Cetirizine hydrochloride | 235 | 15.0K | £727 | -53.0% ▼ |
| Hydroxychloroquine sulfate | 230 | 10.3K | £468 | +18.8% ▲ |
| Hyoscine butylbromide | 228 | 19.6K | £1.5K | -2.2% ▼ |
| Dihydrocodeine tartrate | 225 | 24.0K | £1.6K | +15.2% ▲ |
| Sacubitril/valsartan | 222 | 16.9K | £27.7K | -7.3% ▼ |
| Semaglutide | 222 | 7,075 | £20.3K | -7.8% ▼ |
| Mometasone furoate | 221 | 286 | £2.2K | -45.0% ▼ |
| Diltiazem hydrochloride | 211 | 14.4K | £3.2K | -31.3% ▼ |
| Fentanyl | 211 | 2,167 | £9.0K | +105.9% ▲ |
| Thiamine hydrochloride | 211 | 14.5K | £381 | -60.0% ▼ |
| Bimatoprost | 211 | 3,297 | £2.4K | +41.9% ▲ |
| Topiramate | 209 | 17.7K | £1.1K | +17.6% ▲ |
| Enalapril maleate | 207 | 11.3K | £297 | +15.2% ▲ |
| Estradiol | 207 | 4,999 | £2.5K | -23.3% ▼ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.